Peptilogics, Inc. — Form D
Peptilogics, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-31. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-31
- Form: D
- Accession: 0001663983-17-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 1
- Date of first sale: 2017-08-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-293840
Issuer
- Name: Peptilogics, Inc.
- CIK: 0001663983
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 3710 FORBES AVENUE, PITTSBURGH, PA, 15123
- Phone: (412) 916-7207
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sanjay Kakkar | Director | Pittsburgh, PA |
| Stefan Roever | Director | Pittsburgh, PA |
| Sanjay Kakkar | Executive Officer | Pittsburgh, PA |
| Jason Camm | Director | WALTHAM, MA |
| Stephan Dietrich | Director | Cleveland, OH |
| Dietrich Stephan | Director | Pittsburgh, PA |
| Catherine Mott | Director | Pittsburgh, PA |
| Jonathan Steckbeck | Director | Pittsburgh, PA |
| Jonathan Steckbeck | Executive Officer | Pittsburgh, PA |
| Hannes Holste | Director | Pittsburgh, PA |
Other filings by this issuer (3)
More